Friedman M A, Slater E
Cancer Treat Rev. 1978 Jun;5(2):49-66. doi: 10.1016/s0305-7372(78)80006-1.
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy. Aggressive management including chest tube drainage, with or without instillation of inflammation-inducing drugs, and radiotherapy or surgery in selected cases is indicated for palliative treatment and probably for increased survival. In formulating a treatment plan, attention should be given to a variety of factors including pathogenic forces in the formation of malignant pleural effusion, tissue type of the metastatic malignancy, general clinical status of the patient, the presence of pleural loculations and adhesions, and the exclusion of other non-malignant causes of pleural effusion.
复发性恶性胸腔积液是一个相对常见的问题,常发生于患者恶性疾病终末期前数月。尽管经过仔细评估,通常仍无法确定胸腔积液的确切生理原因,且难以确定切实可行的治疗方案。积极的治疗措施包括胸腔闭式引流(无论是否注入诱导炎症的药物),以及在特定病例中进行放疗或手术,以进行姑息治疗并可能提高生存率。在制定治疗方案时,应考虑多种因素,包括恶性胸腔积液形成的致病因素、转移性恶性肿瘤的组织类型、患者的一般临床状况、胸膜分隔和粘连的存在情况,以及排除胸腔积液的其他非恶性原因。